Q8
(a) (i) Describe the morphological characteristics of *Cryptococcus neoformans* on microscopic examination. Discuss the pathogenesis of Cryptococcosis. 5+5=10 (ii) Define meningococcaemia. Discuss laboratory diagnosis of acute meningococcal meningitis. Briefly write about the available meningococcal vaccines to prevent the disease. 2+5+3=10 (b) (i) Define 'Injury', 'Hurt' and 'Grievous hurt' as per the Indian Penal Code. Write a short note on secondary markings on fired bullet. 6+4=10 (ii) Enumerate different types of finger impressions. Write a short note on DNA fingerprinting. 2+8=10 (c) (i) Elaborate the mechanism of action of Potassium-sparing diuretics. 5 (ii) Briefly describe the therapeutic indications and adverse effects of Zidovudine. 5
हिंदी में प्रश्न पढ़ें
(a) (i) सूक्ष्मदर्शीय जाँच पर क्रिप्टोकोकस नियोफॉर्मन्स की आकारकीय विशेषताओं का वर्णन कीजिए । क्रिप्टोकोक्सता के विकृतिजन की व्याख्या कीजिए । 5+5=10 (ii) मैनिंगोकोकस-रक्तता को परिभाषित कीजिए । तीव्र मैनिंगोकोक्की मस्तिष्कावरणशोथ के प्रयोगशाला में निदान की व्याख्या कीजिए । रोग निवारण के लिए उपलब्ध मैनिंगोकोक्की टीकों (वैक्सीनों) के बारे में संक्षेप में लिखिए । 2+5+3=10 (b) (i) भारतीय दण्ड संहिता के अनुसार 'अभिघात', 'उपहति' तथा 'घोर उपहति' को परिभाषित कीजिए । चली हुई गोली (बुलेट) पर आए द्वितीयक चिह्नों (सेकेंडरी मार्किंग्स) पर एक संक्षिप्त टिप्पणी लिखिए । 6+4=10 (ii) अंगुलियों के विभिन्न प्रकार के छापचिह्नों (इम्प्रेशन्स) को गिनाइए । DNA फिंगरप्रिंटिंग पर एक संक्षिप्त टिप्पणी लिखिए । 2+8=10 (c) (i) पोटेशियम मितव्ययी (स्पेयरिंग) मूत्रल औषधियों के कार्य करने की क्रियाविधि पर प्रकाश डालिए । 5 (ii) ज़िडोवुडीन के चिकित्सार्थ संकेतों तथा प्रतिकूल प्रभावों का संक्षिप्त वर्णन कीजिए । 5
Directive word: Describe
This question asks you to describe. The directive word signals the depth of analysis expected, the structure of your answer, and the weight of evidence you must bring.
See our UPSC directive words guide for a full breakdown of how to respond to each command word.
How this answer will be evaluated
Approach
This multi-part descriptive question requires systematic coverage of four distinct areas: microbiology (20 marks), forensic medicine (20 marks), and pharmacology (10 marks). Allocate approximately 40% time to microbiology parts (a)(i)-(ii), 40% to forensic medicine (b)(i)-(ii), and 20% to pharmacology (c)(i)-(ii). Begin each sub-part with precise definitions where asked, followed by structured elaboration using bullet points or numbered lists for laboratory steps, legal sections, and mechanisms. Include labeled diagrams for Cryptococcus morphology, bullet markings, and DNA fingerprinting techniques. Conclude with public health relevance for infectious disease parts.
Key points expected
- Cryptococcus neoformans: India ink negative staining showing encapsulated budding yeast, narrow-based budding, urease positive; pathogenesis via inhalation → pulmonary focus → hematogenous spread to CNS in immunocompromised (HIV/AIDS)
- Meningococcaemia: definition as presence of N. meningitidis in blood with septicemia; CSF Gram stain, culture on chocolate agar, latex agglutination, PCR; vaccines: MenACWY (conjugate), MenB (Bexsero, Trumenba), Indian availability through UIP
- IPC definitions: Injury (Section 44), Hurt (Section 319), Grievous Hurt (Section 320 with eight clauses); secondary bullet markings: rifling impressions, striations, class vs individual characteristics
- Finger impressions: loop, whorl, arch (plain and tented); DNA fingerprinting: VNTR, STR analysis, Alec Jeffreys technique, forensic applications in paternity and criminal cases
- Potassium-sparing diuretics: spironolactone (aldosterone antagonist), amiloride/triamterene (ENaC blockers) - mechanism at collecting duct principal cells
- Zidovudine: NRTI for HIV, chain terminator, indications in PEP and PMTCT; adverse effects: myelosuppression, lactic acidosis, lipodystrophy, hepatotoxicity
Evaluation rubric
| Dimension | Weight | Max marks | Excellent | Average | Poor |
|---|---|---|---|---|---|
| Concept correctness | 25% | 12.5 | Accurately describes narrow-based budding in Cryptococcus vs broad-based in Blastomyces; correctly cites IPC sections 319, 320 with all eight grievous hurt clauses; precisely explains aldosterone receptor antagonism vs ENaC blockade for potassium-sparing diuretics | Basic definitions correct but minor errors in IPC section numbers, vague on mechanism details, or conflates Cryptococcus morphology with other yeasts | Major factual errors: describes broad-based budding for Cryptococcus, wrong IPC sections, incorrect mechanism of diuretics, or confuses zidovudine with other NRTIs |
| Clinical correlation | 20% | 10 | Links Cryptococcus to HIV/AIDS epidemiology in India (prevalence in CD4 <100); connects meningococcal disease outbreaks (Delhi, Tripura) to vaccine policy; relates zidovudine to PMTCT under India's ART program; applies forensic concepts to real criminal cases | Mentions clinical associations superficially without Indian context or specific epidemiological data | No clinical correlation attempted; purely theoretical descriptions without disease context or public health relevance |
| Diagram / pathway | 20% | 10 | Labeled diagram of encapsulated Cryptococcus with India ink halo; bullet cross-section showing lands, grooves, and striations; DNA fingerprinting autoradiograph pattern; nephron diagram showing diuretic site of action at late distal tubule/collecting duct | Mentions diagrams but poorly labeled or generic sketches without specific morphological details | No diagrams attempted where clearly required; or incorrect diagrams (e.g., bacterial morphology for fungal pathogen) |
| Differential / staging | 15% | 7.5 | Differentiates Cryptococcus from Candida (pseudohyphae), Histoplasma (intracellular), and Pneumocystis; distinguishes meningococcal from pneumococcal and tuberculous meningitis; contrasts grievous hurt with simple hurt and actual bodily harm; differentiates DNA fingerprinting from conventional fingerprinting | Limited differential points, mostly listing without distinguishing features | No differential diagnosis or staging attempted; fails to distinguish between similar entities in any sub-part |
| Management / public-health angle | 20% | 10 | Mentions amphotericin B + flucytosine induction for cryptococcal meningitis per WHO guidelines; discusses MenACWY vaccine in India's UIP for Haj pilgrims and outbreak response; emphasizes zidovudine in Option B+ for PMTCT; notes DNA fingerprinting in Nirbhaya case and CODIS database relevance | Basic treatment mentioned without regimen details; generic vaccine information without Indian policy context | No management or public health aspects covered; omits preventive strategies entirely |
Practice this exact question
Write your answer, then get a detailed evaluation from our AI trained on UPSC's answer-writing standards. Free first evaluation — no signup needed to start.
Evaluate my answer →More from Medical Science 2023 Paper I
- Q1 A 35-year-old male smoker with complaints of difficulty in swallowing and ulcer on tip of his tongue for last one month, visits an ENT surg…
- Q2 A 56-year-old male visits a surgery OPD with complaints of difficulty in passage of urine especially on straining. Based on his clinical ex…
- Q3 (a) (i) Describe the following regarding the knee joint : (I) All movements including locking and unlocking with muscles responsible for ea…
- Q4 (a) (i) Describe the role of SRY (Sex-determining region on Y gene) transcription factors in testicular development. 10 (ii) Describe Vitel…
- Q5 (a) Enumerate various classes of antihypertensive drugs. Briefly discuss the role of calcium channel blockers in the treatment of hypertens…
- Q6 (a) (i) Enumerate any five risk factors for oral cancer. Describe its morphology. 5+5=10 (ii) Enumerate five causes of membranous glomerulo…
- Q7 (a) Classify the various types of poisons. Enumerate the features of Plumbism. Discuss the tests which will show/establish the onset of ear…
- Q8 (a) (i) Describe the morphological characteristics of *Cryptococcus neoformans* on microscopic examination. Discuss the pathogenesis of Cry…